| Code | Description | Claims | Beneficiaries | Total Paid |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,931 |
14,032 |
$5.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,676 |
26,981 |
$3.63M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,356 |
26,922 |
$3.28M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,512 |
18,440 |
$2.67M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,175 |
7,035 |
$1.73M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,200 |
6,335 |
$1.52M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,904 |
6,308 |
$661K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,471 |
4,374 |
$660K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,268 |
5,603 |
$552K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,050 |
1,759 |
$424K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,366 |
2,761 |
$422K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,188 |
1,184 |
$421K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,844 |
1,614 |
$408K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,042 |
1,597 |
$403K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,756 |
2,012 |
$391K |
| 80053 |
Comprehensive metabolic panel |
44,490 |
36,248 |
$285K |
| G0378 |
Hospital observation service, per hour |
4,369 |
2,045 |
$237K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,322 |
1,937 |
$180K |
| 36415 |
Collection of venous blood by venipuncture |
60,622 |
46,298 |
$156K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,380 |
642 |
$140K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
487 |
432 |
$126K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,917 |
11,845 |
$120K |
| 82805 |
|
3,990 |
3,144 |
$115K |
| 84484 |
|
24,438 |
19,829 |
$104K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,419 |
1,222 |
$102K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,911 |
10,733 |
$100K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,429 |
750 |
$97K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,349 |
7,284 |
$96K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
693 |
600 |
$95K |
| 93976 |
|
744 |
565 |
$91K |
| 59025 |
Fetal non-stress test |
612 |
400 |
$89K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
701 |
338 |
$88K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
591 |
450 |
$84K |
| 70496 |
|
357 |
284 |
$83K |
| 71046 |
Radiologic examination, chest; 2 views |
8,593 |
7,812 |
$68K |
| 71250 |
|
712 |
627 |
$61K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
9,755 |
8,658 |
$60K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,770 |
17,095 |
$57K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
260 |
252 |
$54K |
| 83605 |
|
18,336 |
15,101 |
$48K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
555 |
485 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60,820 |
48,779 |
$46K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
613 |
304 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,494 |
2,299 |
$44K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
863 |
791 |
$44K |
| 71045 |
Radiologic examination, chest; single view |
16,030 |
13,762 |
$43K |
| 96367 |
|
832 |
549 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,729 |
8,226 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,350 |
2,182 |
$38K |
| 70491 |
|
139 |
90 |
$36K |
| 73630 |
|
1,048 |
947 |
$36K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,164 |
20,779 |
$34K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,584 |
1,324 |
$32K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
129 |
115 |
$32K |
| 80329 |
|
2,302 |
2,068 |
$31K |
| 76536 |
|
297 |
271 |
$31K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
179 |
143 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
602 |
478 |
$29K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
172 |
153 |
$27K |
| 80320 |
|
3,484 |
3,040 |
$26K |
| 94060 |
|
309 |
278 |
$25K |
| 72100 |
|
789 |
693 |
$24K |
| 71271 |
|
132 |
127 |
$24K |
| 93971 |
|
357 |
312 |
$24K |
| J3490 |
Unclassified drugs |
3,375 |
1,877 |
$23K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
427 |
276 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,412 |
5,533 |
$20K |
| 93017 |
|
236 |
206 |
$20K |
| 73130 |
|
705 |
622 |
$20K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
987 |
902 |
$19K |
| 73610 |
|
709 |
630 |
$19K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
43 |
38 |
$18K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
28 |
27 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
99 |
96 |
$17K |
| 73030 |
|
791 |
669 |
$17K |
| 97161 |
|
672 |
570 |
$17K |
| 96368 |
|
283 |
179 |
$17K |
| 73560 |
|
833 |
738 |
$17K |
| 76642 |
|
138 |
122 |
$16K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
160 |
137 |
$16K |
| 74018 |
|
887 |
758 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,999 |
7,046 |
$16K |
| 81001 |
|
35,592 |
30,611 |
$15K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
42 |
26 |
$15K |
| 64483 |
|
37 |
36 |
$14K |
| 12001 |
|
99 |
69 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,581 |
1,411 |
$14K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
45 |
36 |
$14K |
| 80061 |
Lipid panel |
1,475 |
1,356 |
$13K |
| 72131 |
|
221 |
191 |
$13K |
| 82248 |
|
23,111 |
19,353 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,346 |
14,711 |
$12K |
| 62323 |
|
38 |
38 |
$12K |
| 87040 |
|
6,118 |
5,224 |
$12K |
| 97162 |
|
348 |
312 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,645 |
4,258 |
$11K |
| 73110 |
|
392 |
330 |
$10K |
| 86900 |
|
908 |
713 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
878 |
806 |
$10K |
| 90715 |
|
603 |
470 |
$9K |
| 73502 |
|
403 |
346 |
$8K |
| 82077 |
|
7,019 |
5,546 |
$8K |
| 84703 |
|
15,238 |
13,182 |
$8K |
| 85610 |
|
14,953 |
12,507 |
$8K |
| 70486 |
|
171 |
144 |
$7K |
| 70498 |
|
337 |
266 |
$7K |
| 85027 |
|
2,646 |
1,952 |
$7K |
| 86850 |
|
729 |
577 |
$7K |
| 72050 |
|
130 |
119 |
$7K |
| 83735 |
|
8,471 |
6,841 |
$6K |
| 86140 |
|
4,707 |
3,985 |
$6K |
| 87154 |
|
61 |
43 |
$6K |
| 83655 |
|
198 |
197 |
$6K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
13 |
$6K |
| 73564 |
|
129 |
121 |
$6K |
| 94726 |
|
145 |
128 |
$6K |
| 73080 |
|
203 |
164 |
$6K |
| 96376 |
|
4,341 |
2,961 |
$6K |
| 82728 |
|
824 |
713 |
$6K |
| 85018 |
|
4,834 |
3,889 |
$6K |
| 87070 |
|
726 |
560 |
$6K |
| 94729 |
|
201 |
178 |
$6K |
| 36416 |
|
508 |
353 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
658 |
522 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
79 |
30 |
$5K |
| 97165 |
|
75 |
70 |
$5K |
| 82607 |
|
590 |
516 |
$5K |
| 83880 |
|
4,169 |
3,573 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,472 |
1,241 |
$5K |
| 83690 |
|
14,816 |
12,796 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
659 |
523 |
$4K |
| 80143 |
|
4,695 |
3,838 |
$4K |
| 64635 |
|
20 |
14 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20,122 |
15,011 |
$4K |
| 74174 |
|
37 |
25 |
$4K |
| 87077 |
|
1,535 |
1,327 |
$3K |
| J3535 |
Drug administered through a metered dose inhaler |
385 |
257 |
$3K |
| 80361 |
|
151 |
137 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
655 |
509 |
$3K |
| 84439 |
|
761 |
647 |
$3K |
| 72072 |
|
82 |
66 |
$3K |
| 45384 |
|
12 |
12 |
$3K |
| 80051 |
|
3,909 |
3,516 |
$3K |
| 92523 |
|
40 |
39 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
85 |
39 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
598 |
476 |
$3K |
| 80179 |
|
4,419 |
3,614 |
$2K |
| 86703 |
|
171 |
149 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,738 |
5,585 |
$2K |
| 83540 |
|
722 |
634 |
$2K |
| 71101 |
|
131 |
111 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
699 |
514 |
$2K |
| 87480 |
|
335 |
285 |
$2K |
| 93880 |
|
28 |
26 |
$2K |
| 85379 |
|
2,328 |
1,920 |
$2K |
| 76830 |
Ultrasound, transvaginal |
185 |
152 |
$2K |
| 83550 |
|
708 |
620 |
$2K |
| 87420 |
|
325 |
280 |
$2K |
| 80353 |
|
169 |
165 |
$2K |
| 80349 |
|
169 |
165 |
$2K |
| 80356 |
|
168 |
164 |
$2K |
| 80076 |
|
3,412 |
3,094 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
444 |
175 |
$2K |
| 83992 |
|
129 |
125 |
$2K |
| 80348 |
|
155 |
137 |
$2K |
| 87186 |
|
1,265 |
1,090 |
$2K |
| 80373 |
|
151 |
137 |
$2K |
| 80365 |
|
152 |
137 |
$2K |
| 82043 |
|
190 |
176 |
$2K |
| 80358 |
|
151 |
137 |
$2K |
| 82570 |
|
554 |
476 |
$2K |
| 73140 |
|
41 |
37 |
$2K |
| 20552 |
|
13 |
12 |
$2K |
| 80354 |
|
150 |
136 |
$2K |
| 80321 |
|
140 |
136 |
$2K |
| 80324 |
|
141 |
137 |
$1K |
| 80372 |
|
136 |
122 |
$1K |
| 86901 |
|
907 |
713 |
$1K |
| 80359 |
|
129 |
125 |
$1K |
| 80346 |
|
128 |
124 |
$1K |
| 80360 |
|
126 |
122 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
781 |
411 |
$1K |
| 82565 |
|
3,992 |
3,584 |
$1K |
| 85652 |
|
511 |
430 |
$1K |
| 84702 |
|
559 |
399 |
$1K |
| 85730 |
|
4,188 |
3,474 |
$1K |
| 80362 |
|
114 |
110 |
$1K |
| 87205 |
|
951 |
758 |
$1K |
| 82550 |
|
1,366 |
1,083 |
$1K |
| 20610 |
|
13 |
12 |
$1K |
| 86803 |
|
140 |
124 |
$985.27 |
| 82746 |
|
250 |
221 |
$970.66 |
| 82947 |
|
3,931 |
3,533 |
$950.73 |
| 85007 |
|
708 |
556 |
$949.45 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,944 |
12,051 |
$915.36 |
| 87510 |
|
335 |
285 |
$910.04 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,958 |
14,583 |
$879.73 |
| 82140 |
|
500 |
372 |
$824.71 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
765 |
555 |
$814.69 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,823 |
7,458 |
$786.18 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,077 |
572 |
$776.42 |
| 84153 |
|
99 |
93 |
$770.51 |
| 76870 |
|
17 |
13 |
$678.72 |
| 76801 |
|
25 |
16 |
$676.14 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
619 |
570 |
$635.46 |
| 83921 |
|
126 |
118 |
$626.52 |
| 84520 |
|
3,911 |
3,519 |
$617.85 |
| 80055 |
|
33 |
33 |
$593.19 |
| 73552 |
|
13 |
13 |
$585.22 |
| J2770 |
Injection, quinupristin/dalfopristin, 500 mg (150/350) |
34 |
27 |
$564.02 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
12 |
12 |
$556.86 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,497 |
1,528 |
$520.23 |
| 87899 |
|
35 |
35 |
$519.00 |
| 84100 |
|
416 |
324 |
$481.71 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,125 |
1,249 |
$472.32 |
| 80074 |
|
93 |
72 |
$464.37 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,070 |
728 |
$461.49 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
23 |
15 |
$450.76 |
| 87653 |
|
14 |
13 |
$444.32 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
300 |
278 |
$419.74 |
| 86308 |
|
408 |
301 |
$405.20 |
| 80305 |
|
27 |
14 |
$389.60 |
| 86592 |
|
79 |
71 |
$358.40 |
| 94727 |
|
31 |
29 |
$357.12 |
| 36600 |
|
225 |
178 |
$351.30 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
17 |
12 |
$349.75 |
| 87075 |
|
300 |
231 |
$346.91 |
| 87660 |
|
47 |
41 |
$336.58 |
| 73090 |
|
48 |
38 |
$334.30 |
| 73590 |
|
66 |
60 |
$333.10 |
| J2704 |
Injection, propofol, 10 mg |
2,041 |
1,469 |
$332.66 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
901 |
659 |
$317.44 |
| J3360 |
Injection, diazepam, up to 5 mg |
394 |
284 |
$295.88 |
| 51701 |
|
177 |
141 |
$287.04 |
| J7999 |
Compounded drug, not otherwise classified |
67 |
43 |
$250.37 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,027 |
791 |
$244.50 |
| C9113 |
Injection, pantoprazole sodium, per vial |
262 |
156 |
$236.84 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
858 |
668 |
$229.12 |
| 87081 |
|
87 |
84 |
$217.62 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
413 |
385 |
$205.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,355 |
1,582 |
$186.15 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
90 |
61 |
$181.28 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
99 |
96 |
$181.01 |
| 82010 |
|
190 |
122 |
$176.58 |
| 87486 |
|
17 |
12 |
$174.88 |
| 80164 |
|
19 |
12 |
$159.04 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
450 |
394 |
$154.20 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,874 |
1,408 |
$147.02 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,631 |
895 |
$142.09 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,808 |
1,351 |
$132.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,364 |
1,009 |
$124.52 |
| 87147 |
|
162 |
126 |
$123.52 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
119 |
74 |
$117.99 |
| 84156 |
|
108 |
82 |
$102.97 |
| 87581 |
|
17 |
12 |
$100.92 |
| 80202 |
|
16 |
12 |
$99.48 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
17 |
12 |
$89.92 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
310 |
164 |
$87.42 |
| 88304 |
|
44 |
24 |
$86.77 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
319 |
115 |
$68.75 |
| 80069 |
|
13 |
13 |
$68.26 |
| J1630 |
Injection, haloperidol, up to 5 mg |
343 |
224 |
$56.39 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
645 |
451 |
$47.03 |
| 85014 |
|
14 |
12 |
$45.77 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
95 |
92 |
$41.87 |
| J0703 |
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
103 |
54 |
$41.76 |
| 82150 |
|
89 |
80 |
$39.31 |
| 83615 |
|
17 |
16 |
$34.14 |
| J2060 |
Injection, lorazepam, 2 mg |
581 |
442 |
$33.90 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
436 |
337 |
$33.13 |
| 87807 |
|
137 |
129 |
$33.00 |
| 84550 |
|
24 |
12 |
$28.45 |
| J3480 |
Injection, potassium chloride, per 2 meq |
327 |
175 |
$25.96 |
| 86618 |
|
16 |
13 |
$23.99 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
69 |
45 |
$17.25 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
247 |
196 |
$14.16 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
247 |
217 |
$12.59 |
| 82962 |
|
97 |
66 |
$11.78 |
| J1644 |
Injection, heparin sodium, per 1000 units |
216 |
101 |
$11.20 |
| J1940 |
Injection, furosemide, up to 20 mg |
116 |
79 |
$11.09 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
416 |
346 |
$7.34 |
| J1790 |
Injection, droperidol, up to 5 mg |
16 |
12 |
$6.42 |
| J0456 |
Injection, azithromycin, 500 mg |
22 |
13 |
$2.88 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
329 |
202 |
$1.50 |
| J7510 |
Prednisolone oral, per 5 mg |
14 |
12 |
$1.44 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
47 |
38 |
$0.45 |
| 64636 |
|
20 |
14 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
20 |
16 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
13 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
61 |
52 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
78 |
74 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
19 |
18 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
16 |
12 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
12 |
$0.00 |